Fails 3 of 8 criteria. S3, pharmacy identification: The terms and treatment pages refer to licensed pharmacies without identifying the dispensing facility by name. 2 more criteria also fail; see the table below.
At a glance
Tablet HealthTelehealth service
4/8criteria passed
Price
Printed on its own pages before sign-up
Sells
compounded semaglutide, oral semaglutide, compounded tirzepatide, and 1 more
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSThe terms require a provider to find the treatment clinically appropriate and write a valid prescription before forwarding it for fulfillment.Source: Tablet Health's terms of service page.
S2NOT VERIFIEDThe payment-sequence question did not resolve from the published material. The public pages require a prescription but do not establish whether payment is collected before the medical evaluation. The check is open.Source: Tablet Health's terms of service page; Tablet Health's telehealth page.
S3FAILThe terms and treatment pages refer to licensed pharmacies without identifying the dispensing facility by name.Source: Tablet Health's terms of service page; Tablet Health's compounded tirzepatide product page.
S4FAILThe oral semaglutide page advertises FDA-approved ingredients and a statements-not-approved disclaimer, rather than clearly stating that the compounded medication itself is not FDA-approved.Source: Tablet Health's oral semaglutide product page; Tablet Health's compounded tirzepatide product page.
S5FAILThe treatment pages publish no certificate of analysis or equivalent lot document.Source: Tablet Health's compounded semaglutide product page; Tablet Health's compounded tirzepatide product page.
S6PASSThe telehealth consent lists 732 S 6th St, Ste N, Las Vegas, NV 89101.Source: Tablet Health's telehealth consent.
S7PASSInjectable semaglutide is $89.99 for the first month, then $139.99 a month. Oral semaglutide is $89.99 initially, then $149.99 a month. Injectable and oral tirzepatide are $129.99 for the first month, then $199.99 a month.Source: Tablet Health's compounded semaglutide product page; Tablet Health's oral semaglutide product page; Tablet Health's compounded tirzepatide product page; Tablet Health's oral tirzepatide product page.
S8PASSNo FDA warning letter names Tablet Health or Tablet LLC, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, oral semaglutide, compounded tirzepatide, oral tirzepatide.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.